Meta Accelerates Metaverse Innovation With Hyperscape Capture

by THEFUTURE.TEAM

September 19, 2025

Meta Connect Unveils Photorealistic VR Breakthrough

Today’s Meta Connect conference showcased a blend of futuristic smart glasses and groundbreaking metaverse advancements. A highlight was the introduction of Hyperscape Capture, an evolution of the previously demoed Hyperscape technology, which empowers developers and creators to transform real-world spaces into photorealistic virtual environments.

Transforming Physical Rooms Into Digital Masterworks

Hyperscape Capture is now available in Early Access for Quest device users, offering an innovative scanning process that converts a physical room into an immersive digital replica. Although the capture only takes a few minutes, its subsequent rendering requires several hours to produce a high-fidelity virtual space. Initially, users will experience these immersive environments in isolation; however, Meta plans to enable private sharing through unique links in the near future.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Real-World Inspirations Fuel Digital Creativity

The technology is already at work, rendering virtual versions of iconic spaces such as Gordon Ramsay’s L.A. kitchen, Chance the Rapper’s House of Kicks, and the famed UFC Apex Octagon. Even niche environments, like Happy Kelli’s room filled with her Crocs collection, have been recreated with impressive detail. Utilizing advanced techniques like Gaussian Splatting, cloud rendering, and streaming, Meta ensures that these digital worlds maintain a remarkably lifelike presence when viewed through the Meta Quest 3 headset.

Expanding The Metaverse Experience

In addition to Hyperscape Capture, Meta rolled out a slate of new metaverse experiences at the conference. Fall VR releases include titles such as Marvel’s Deadpool VR, ILM’s Star Wars: Beyond Victory, and Demeo x Dungeons & Dragons: Battlemarked and Reach. Furthermore, Horizon TV is broadening its streaming repertoire with support for platforms like Disney+, ESPN, and Hulu, while strategic partnerships with Universal Pictures and Blumhouse are set to introduce immersive special effects on blockbuster films such as “M3GAN” and “The Black Phone.” A limited-time 3D preview of “Avatar: Fire and Ash” also underscores Meta’s commitment to merging entertainment with technological innovation.

Looking Forward

While the initial rollout of Hyperscape Capture is limited to Meta’s Quest 3 and Quest 3S devices for users aged 18 and up, its gradual release indicates a larger strategy to enhance digital engagement. As Meta continues to refine its metaverse capabilities, the potential to seamlessly blend the physical and digital worlds reinforces its position at the forefront of virtual innovation.

The Future Forbes Realty Global Properties

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

by THEFUTURE.TEAM

October 27, 2026

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.

Breaking news